Enoki Inflammation and Immunomodulation
Explore mushroom research and guides on enoki inflammation and immunomodulation.
Enoki and Gut Inflammation: Colitis Research
Two independent studies found enoki polysaccharides reduce colitis in mice by different mechanisms. Here's what each study showed and what it means.
Enoki and Inflammation: Anti-Inflammatory Mechanisms
Enoki contains a protein (FIP-fve) and polysaccharides that reduce inflammation via different pathways. Here's what the cell and animal studies show.
Enoki for Inflammatory Conditions: Research Review
What conditions does enoki mushroom research actually cover? IBD, metabolic inflammation, and immune activation have the strongest preclinical evidence. Here's the honest breakdown.
Enoki FIP-fve and NF-kB Pathway Modulation
FIP-fve is enoki's 114-amino-acid immunomodulatory lectin. It activates T-cells via MAP2K3/p38α MAPK and suppresses NF-κB in cancer cells: two pathways, one protein. Here's the full science.
Flammulina velutipes NF-κB: Two Pathways, One Mushroom
Flammulina velutipes modulates NF-κB via two pathways: FIP-fve protein via p38 MAPK and polysaccharides via RSAD2. A summary of the preclinical evidence.